Cargando…

Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures

INTRODUCTION: Cognitive impairment is a common complication of Parkinson's disease (PD) and identifying risk factors for progression to Parkinson's disease dementia (PDD) is important. However, little research has been done comparing the utility of commonly used cognitive screening tests i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hojoong M., Nazor, Carter, Zabetian, Cyrus P., Quinn, Joseph F., Chung, Kathryn A., Hiller, Amie L., Hu, Shu-Ching, Leverenz, James B., Montine, Thomas J., Edwards, Karen L., Cholerton, Brenna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197868/ https://www.ncbi.nlm.nih.gov/pubmed/32368733 http://dx.doi.org/10.1016/j.prdoa.2019.08.006

Ejemplares similares

Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease
por: Morris, Rosie, et al.
Publicado: (2022)

Multivariate prediction of dementia in Parkinson’s disease
por: Phongpreecha, Thanaphong, et al.
Publicado: (2020)

Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson’s disease
por: Morris, Rosie, et al.
Publicado: (2023)

Resting-State Cerebello-Cortical Dysfunction in Parkinson's Disease
por: Palmer, William C., et al.
Publicado: (2021)

Sensorimotor Inhibition and Mobility in Genetic Subgroups of Parkinson's Disease
por: Martini, Douglas N., et al.
Publicado: (2020)

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach
por: Cholerton, Brenna, et al.
Publicado: (2016)

Diagnostic Validation for Participants in the Washington State Parkinson Disease Registry
por: Kim, Hojoong M., et al.
Publicado: (2018)

Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid
por: Hwangbo, Nathan, et al.
Publicado: (2022)

Quantitative estimate of cognitive resilience and its medical and genetic associations
por: Phongpreecha, Thanaphong, et al.
Publicado: (2023)

The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease
por: Mata, Ignacio F., et al.
Publicado: (2015)

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
por: Lin, Xiangmin, et al.
Publicado: (2012)

Association Between the Ubiquitin Carboxyl-Terminal Esterase L1 Gene (UCHL1) S18Y Variant and Parkinson's Disease: A HuGE Review and Meta-Analysis
por: Ragland, Margaret, et al.
Publicado: (2009)

Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype
por: Cooper, Christine A., et al.
Publicado: (2016)

Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
por: Tumas, Vitor, et al.
Publicado: (2016)

Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial
por: Craft, Suzanne, et al.
Publicado: (2017)

A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?
por: Hiller, Amie L., et al.
Publicado: (2018)

White Matter Hyperintensities Related to Parkinson's Disease Executive Function
por: Linortner, Patricia, et al.
Publicado: (2020)

Associations Between Amantadine Usage, Gait, and Cognition in PSP: A post-hoc Analysis of the Davunetide Trial
por: Dale, Marian L., et al.
Publicado: (2020)

Cognition among individuals along a spectrum of increased risk for Parkinson’s disease
por: Chahine, Lana M., et al.
Publicado: (2018)

Concepts for brain aging: resistance, resilience, reserve, and compensation
por: Montine, Thomas J., et al.
Publicado: (2019)

Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
por: Weintraub, Daniel, et al.
Publicado: (2020)

Targeted Discovery and Validation of Plasma Biomarkers of Parkinson’s Disease
por: Pan, Catherine, et al.
Publicado: (2014)

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases
por: Montine, Thomas J., et al.
Publicado: (2015)

Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region
por: Hill-Burns, Erin M., et al.
Publicado: (2011)

PNPLA6‐Related Disorder with Levodopa‐Responsive Parkinsonism
por: Kazanci, Serdar, et al.
Publicado: (2022)

Functional topologies of spatial cognition predict cognitive and motor progression in Parkinson’s
por: Harrington, Deborah L., et al.
Publicado: (2022)

Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson’s Disease
por: Hossein-nezhad, Arash, et al.
Publicado: (2016)

Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment
por: Russin, Kate J., et al.
Publicado: (2021)

Feasibility and Acceptability of Computerised Cognitive Training of Everyday Cognition in Parkinson's Disease
por: Smith, S. J., et al.
Publicado: (2019)

Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
por: Hoekstra, Jake G, et al.
Publicado: (2011)

Cytokine Profile in Plasma Extracellular Vesicles of Parkinson’s Disease and the Association with Cognitive Function
por: Chan, Lung, et al.
Publicado: (2021)

Parkinson's Disease and Cognitive Impairment
por: Yang, Yang, et al.
Publicado: (2016)

Plasticity-related gene 3 (LPPR1) and age at diagnosis of Parkinson disease
por: Wallen, Zachary D., et al.
Publicado: (2018)

Subjective Cognitive Complaints and Objective Cognitive Impairment in Parkinson's Disease
por: Hong, Jin Yong, et al.
Publicado: (2018)

Characterization of cognition in mild cognitive impairment with and without Parkinson's disease
por: Auclair-Ouellet, N., et al.
Publicado: (2020)

Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
por: Stewart, Tessandra, et al.
Publicado: (2015)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
por: Leroi, Iracema, et al.
Publicado: (2012)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
por: Wallen, Zachary D., et al.
Publicado: (2021)

Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease
por: Jeon, Junbeom, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5dlho3tcjfpfpc0gc56a9nlgeb